Keyphrases
Albumin-to-creatinine Ratio
42%
Albuminuria
28%
Background Population
14%
Blood Pressure
14%
Cardiovascular Risk Markers
14%
Changes in Risk
28%
Clinical Outcomes
14%
Clinical Trials
14%
Clinically Significant
14%
Confidence Interval
57%
Cox Model
14%
Dapagliflozin
100%
Diabetic Kidney Disease
14%
Drug Effects
14%
Drug-induced
14%
Glucose Control
14%
Heart Failure Events
28%
Heart Failure Outcomes
100%
Impaired Kidney Function
14%
Kidney
14%
Kidney Events
14%
Kidney Failure
100%
Multiple Risk Factors
100%
Multivariable
14%
Outcome Trials
14%
Outcome-based
100%
Placebo
14%
Pooled Database
14%
Response Rate
57%
Risk Change
14%
Risk Markers
100%
Risk Reduction
14%
Short-term Change
100%
Simulation Analysis
14%
Sodium-glucose Cotransporter
14%
Type 2 Diabetes Mellitus (T2DM)
42%
Type 2 Diabetic Patients
14%
Pharmacology, Toxicology and Pharmaceutical Science
Albuminuria
28%
Cardiovascular Risk
14%
Clinical Trial
14%
Creatinine
42%
Dapagliflozin
100%
Diabetic Nephropathy
14%
Heart Failure
100%
Kidney Failure
100%
Non Insulin Dependent Diabetes Mellitus
14%
Placebo
14%
Sodium Glucose Cotransporter 2
14%